Evidence map›Paper›PMID 22687616›Full record

ReviewThe Journal of physiology2012

Nitric oxide formation versus scavenging: the red blood cell balancing act.

Benjamin Y Owusu, Ryan Stapley, Rakesh P Patel

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. An Overview of NO Signaling Pathways in Aging.Molecules (Basel, Switzerland) · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. CO2 has no therapeutic effect on early microvasospasm after experimental subarachnoid hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Article
  15. Hemoglobin α in the blood vessel wall.Free radical biology & medicine · 2014
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Benjamin Y OwusuDepartment of Pathology, University of Alabama at Birmingham, 901 19th Street South, BMRII 532, Birmingham, AL 35294, USA.
Ryan Stapley
Rakesh P Patel
University of Alabama at Birmingham · US

Funding

RBC age and potentiation of transfusion related pathology in trauma patientsR01HL095468 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNUM, SCOTT R, PATEL, RAKESH P. · 2009 to 2012
$1.5M
Role of hemoglobin b93cys residue in nitric oxide bioactivityR01HL092624 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PATEL, RAKESH P. · 2010 to 2013
$1.5M
NHLBI NIH HHS HL092624NHLBI NIH HHS HL095468NHLBI NIH HHS R01 HL092624NHLBI NIH HHS R01 HL095468
6 · The paper itself

Abstract

Nitric oxide (NO) is a key modulator of vascular homeostasis controlling critical functions related to blood flow, respiration, cell death and proliferation, and protecting the vasculature from pro-inflammatory and coagulative stresses. Inhibition of NO formation, and/or diversion of NO away from its physiological signalling targets lead to dysregulated NO bioavailability, a hallmark of numerous vascular and pulmonary diseases. Current concepts suggest that the balance between NO formation and NO scavenging is critical in disease development, with the corollary being that redressing the balance offers a target for therapeutic intervention. Evidence presented over the last two decades has seen red blood cells (RBCs) and haemoglobin specifically emerge as prominent effectors in this paradigm. In this symposium review article, we discuss recent insights into the mechanisms by which RBCs may modulate the balance between NO-formation and inhibition. We discuss how these mechanisms may become dysfunctional to cause disease, highlight key questions that remain, and discuss the potential impact of these insights on therapeutic opportunities.

Indexed as

AnimalsErythrocytesHemoglobinsHumansNitric OxideNitritesHemoglobinsNitric OxideNitrites

Identifiers

PMID22687616
PMCPMC3497558
OpenAlexW2126050049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.